Entrada Therapeutics (TRDA) Interest Coverage Ratio (2020 - 2026)
Entrada Therapeutics' (TRDA) quarterly Interest Coverage Ratio came in at 2350.17 in Q1 2026, down 1345.26% year-on-year from 188.73 in Q1 2025, and up 10.09% quarter-over-quarter from 2613.94 in Q3 2025.
Entrada Therapeutics (TRDA) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Entrada Therapeutics' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 2350.17 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 1345.26% year-over-year to 2350.17 in Q1 2026; TTM through Mar 2026 was 9911.72, a 32431.32% decrease from a year earlier, with the FY2025 full-year figure at 12.48, down 1770.16% from the prior year.
- Interest Coverage Ratio advanced to 2350.17 in Q1 2026 per TRDA's latest filing, from 2613.94 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 151.34 in Q2 2024 and bottomed at 2707.25 in Q3 2024.
- The 5-year median for Interest Coverage Ratio is 0.69 (2022), against an average of 501.03.
- Biggest YoY gain for Interest Coverage Ratio was 95178.89% in 2024; the steepest drop was 170626.61% in 2024.
- Year by year, Interest Coverage Ratio stood at 4.56 in 2022, then plunged by 108.17% to 0.37 in 2023, then soared by 74.98% to 0.09 in 2024, then sank by 2803998.1% to 2613.94 in 2025, then climbed by 10.09% to 2350.17 in 2026.
- Per Business Quant, the three latest TRDA Interest Coverage Ratio figures stand at 2350.17 (Q1 2026), 2613.94 (Q3 2025), and 410.96 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Entrada Therapeutics | 253.11 Mn | 253.11 Mn | - | -2,350.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,350.17 |
| Sep 30, 2025 | -2,613.94 |
| Jun 30, 2025 | -410.96 |
| Mar 31, 2025 | -162.61 |
| Dec 31, 2024 | -0.09 |
| Sep 30, 2024 | -2,707.25 |
| Jun 30, 2024 | 151.34 |
| Mar 31, 2024 | 74.87 |
| Dec 31, 2023 | -0.37 |
| Sep 30, 2023 | 1.59 |
| Jun 30, 2023 | -0.16 |
| Mar 31, 2023 | -1.07 |
| Dec 31, 2022 | 4.56 |
| Sep 30, 2022 | -0.88 |
| Jun 30, 2022 | -0.74 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | -0.64 |
| Sep 30, 2021 | -0.72 |
| Dec 31, 2020 | -0.65 |